RUNX3 and cancer: Collectively, these findings underscore RUNX3's role as a tumor-suppressive gene in mediating drug resistance, highlighting its context-dependent impact across various cancer types and therapeutic approaches, thereby deepening our understanding of the RUNX family's tumor-suppressive influence on drug resistance.